Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimenJade Ghosn, Jean-François Delfraissy, Giampiero Carosi et al.|Antiviral Therapy|2010Cited by 39
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV InfectionAdriana Ammassari, Andrea Antinori, Laura Ravasio et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2001Cited by 36